Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Follicular Lymphoma
Related studies linked through entity extraction aliases.
A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Axicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Follicular Lymphoma With High Dose Therapy and Stem Cell Support Followed by Rituximab and Alpha Interferon
- Status
- COMPLETED
- Phase
- PHASE2
Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL
- Status
- COMPLETED
- Phase
- PHASE1
Open-Label, Multi-Center, Two-Part, Ph1 Study to Characterize the PKs of an Intravenous Micro-Dose of [14C]-Tazemetostat (EPZ 6438) and the ADME of an Oral [14C]-Labeled Dose of Tazemetostat in Subjects With B-Cell Lymphomas or Adv Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers
- Status
- UNKNOWN
- Phase
- PHASE3
CD180 Overexpression in Follicular Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE1